Intermolecular Reactions S-6 IV. Determination of Absolute Stereochemistry S-14 V.
1 H NMR Spectra S-15
I. General
The following reagents were purchased and used as received: CPME (Aldrich, anhydrous), TBME (Aldrich, anhydrous), 2,4-dimethoxyphenol (available from Matrix Scientific), and 2-fluoro-6-methoxylphenol (Aldrich). Catalyst 1 is commercially available from Strem Chemicals and Abblis Chemicals.
S-3
13 C NMR (CDCl 3 , 126 MHz) " 166. 5, 151.2, 150.6, 141.8, 135.9, 128.6, 128.4, 128.3, 120.7, 114.9, 112.9, 66.3, 60.2, 55.9, 49.3, 31.8, 23.4; IR (film) 2947 IR (film) , 2831 IR (film) , 1715 IR (film) , 1649 IR (film) , 1618 IR (film) , 1509 IR (film) , 1454 IR (film) , 1367 IR (film) , 1243 IR (film) , 1159 IR (film) , 1038 (R,E)-Methyl 3-(1-(4-methoxyphenyl)pyrrolidin-2-yl)acrylate (Table 1 , entry 3). The title compound was prepared according to the General Procedure from methyl 7-((4-methoxyphenyl)amino)hept-2-ynoate (130 mg, 0.50 mmol). After purification by flash chromatography (4:1 hexanes/ethyl acetate), the title compound was isolated as a light-yellow oil (99 mg, 76% yield) in 94% ee.
HPLC analysis of the product: Diacel CHIRALCEL OD-H column; 1% 2-propanol in hexanes; retention times: 18.9 min (minor), 21.5 min (major).
The second run was performed with the (R)-catalyst. The product was isolated as a lightyellow oil (106 mg, 80% yield) in 94% ee.
1 H NMR (CDCl 3 , 500 MHz) " 7.00 (dd, J = 5.0, 15.5 Hz, 1H), 6.83 (dt, J = 3.5, 9.5 Hz, 2H), 6.51 (dt, J = 4.0, 9.0 Hz, 2H), 5.91 (dd, J = 1.5, 15.5 Hz, 1H), 4.25-4.20 (m, 1H), 3.76 (s, 3H), 3.73 (s, 3H), 3.55-3.50 (m, 1H), 3.23 (q, J = 8.5 Hz, 1H), 2.22-2.14 (m, 1H), 2.02-1.98 (m, 2H), 1.94-1.86 (m, 1H); 13 C NMR (CDCl 3 , 126 MHz) " 167. 1, 151.2, 150.2, 141.8, 120.6, 114.9, 112.9, 60.1, 55.9, 51.5, 49.2, 31.8, 23.4; IR (film) 2958 IR (film) , 2836 IR (film) , 1723 IR (film) , 1655 IR (film) , 1512 IR (film) , 1436 IR (film) , 1241 IR (film) , 1177 IR (film) , 1042 ; LRMS (LCMS EI): calcd for C 15 H 20 NO 3 (M+H) 262.1, found 262.2; [#] 25 D = +109° (c = 1.00, CHCl 3 ). (Table 1 , entry 4). The title compound was prepared according to the General Procedure from tert-butyl 7-((4-methoxyphenyl)amino)-6,6-dimethylhept-2-ynoate (120 mg, 0.36 mmol). After purification by flash chromatography (10:1$4:1 hexanes/ethyl acetate), the title compound was isolated as a pale-yellow oil (71 mg, 59% yield) in 93% ee.
(R,E)-tert-Butyl 3-(1-(4-methoxyphenyl)-4,4-dimethylpyrrolidin-2-yl)acrylate

S-4
HPLC analysis of the product: Diacel CHIRALCEL OD-H column; 1% 2-propanol in hexanes; retention times: 8.5 min (minor), 12.6 min (major).
The second run was performed with the (R)-catalyst. The product was isolated as a paleyellow oil (72 mg, 60% yield) in 94% ee.
1 H NMR (CDCl 3 , 400 MHz) " 6.88 (dd, J = 6.0, 15.6 Hz, 1H), 2H), 2H), 5.87 (dd, J = 1.6, 15.6 Hz, 1H), 1H), 3.76 (s, 3H), 3.37 (d, J = 8.8 Hz, 1H), 3.07 (d, J = 8.8 Hz 1H), 2.06 (dd, J = 8.4, 12.4 Hz, 1H), 1.72 (dd, J = 6.4, 12.4 Hz, 1H), 1.47 (s, 9H), 1.19 (s, 3H), 1.07 (s, 3H); 13 C NMR (CDCl 3 , 101 MHz) " 166. 2, 151.4, 150.4, 143.0, 122.5, 114.8, 113.7, 80.5, 64.1, 60.7, 56.0, 46.9, 37.9, 28.3, 27.6, 27.5; IR (film) 2952 IR (film) , 2868 IR (film) , 2825 IR (film) , 1707 IR (film) , 1649 IR (film) , 1462 IR (film) , 1391 IR (film) , 1365 IR (film) , 1246 IR (film) , 1146 IR (film) , 1042 
(R,E)-tert-Butyl 3-(indolin-2-yl)acrylate (Table 1, entry 5).
The title compound was prepared according to the General Procedure from tert-butyl 5-(2-aminophenyl)pent-2-ynoate (115 mg, 0.47 mmol). After purification by flash chromatography (10:1$2:1 hexanes/ethyl acetate), the title compound was isolated as a colorless solid (66 mg, 57% yield) in 89% ee.
HPLC analysis of the product: Diacel CHIRALPAK AD-H column; 2% 2-propanol in hexanes; retention times: 18.3 min (minor), 26.6 min (major).
The second run was performed with the (R)-catalyst. The product was isolated as a colorless solid (60 mg, 52% yield) in 90% ee.
1 H NMR (CDCl 3 , 400 MHz) " 7.08-7.00 (m, 2H), 6.92 (dd, J = 6.8, 15.6 Hz, 1H), 6.72 (td, J = 1.2, 7.6 Hz, 1H), 6.60-6.52 (m, 1H), 5.93 (dd, J = 1.2, 15.6 Hz, 1H), 4.47 (q, J = 8.0 Hz, 1H), 3.91 (br s, 1H), 3.26 (dd, J = 9.2, 15.6 Hz, 1H), 2.86 (dd, J = 8.0, 15.6 Hz, 1H), 1.48 (s, 9H); 13 C NMR (CDCl 3 , 101 MHz) " 165. 9, 150.4, 147.7, 127.8, 127.7, 124.9, 123.1, 119.3, 109.5, 80.7, 60.4, 36.3, 28.3; IR (film) 2931 IR (film) , 1710 IR (film) , 1604 IR (film) , 1483 IR (film) , 1467 IR (film) , 1309 IR (film) , 1248 IR (film) , 1148 (R,E)-tert-Butyl 3-(5-methoxyindolin-2-yl)acrylate (Table 1 , entry 6). The title compound was prepared according to the General Procedure from tert-butyl 5-(2-amino-5-methoxyphenyl)pent-2-ynoate (85 mg, 0.31 mmol). After purification by flash chromatography (10:1$4:1 hexanes/ethyl acetate), the title compound was isolated as a pale-yellow solid (39 mg, 46% yield) in 90% ee.
S-5
HPLC analysis of the product: Diacel CHIRALPAK AD-H column; 5% 2-propanol in hexanes; retention times: 14.8 min (minor), 21.7 min (major).
The second run was performed with the (R)-catalyst. 9, 153.7, 147.7, 144.0, 129.4, 123.0, 112.5, 111.6, 110.0, 80.7, 60.8, 56.0, 36.6, 28.2; IR (film) 2979 IR (film) , 2942 IR (film) , 2836 IR (film) , 1808 IR (film) , 1731 IR (film) , 1620 IR (film) , 1504 IR (film) , 1370 IR (film) , 1248 IR (film) , 1154 IR (film) , 1037 (R,E)-tert-Butyl 3-(5-(trifluoromethyl)indolin-2-yl)acrylate (Table 1 , entry 7). The title compound was prepared according to the General Procedure from tert-butyl 5-(2-amino-5-(trifluoromethyl)phenyl)pent-2-ynoate (81 mg, 0.26 mmol). After purification by flash chromatography (10:1$4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless solid (35 mg, 43% yield) in 88% ee.
HPLC analysis of the product: Diacel CHIRALPAK AD-H column; 3% 2-propanol in hexanes; retention times: 16.7 min (minor), 23.7 min (major).
The second run was performed with the (R)-catalyst. The product was isolated as a colorless solid (54 mg, 45% yield) in 87% ee.
1 H NMR (600 MHz, CDCl 3 ) " 7.32-7.26 (m, 2H), 6.88 (dd, J = 7.2, 15.6 Hz, 1H), 6.61 (d, J = 8.8 Hz, 1H), 5.93 (d, J = 1.2, 15.6 Hz, 1H), 1H), 4.17 (s, 1H), 3.31 (dd, J = 9.6, 16 .0 Hz, 1H), 2.89 (dd, J = 7.6, 16.0 Hz, 1H), 1.48 (s, 9H); 13 C NMR (CDCl 3 , 126 MHz) " 165. 5, 153.0, 146.6, 127.7, 124 .9 (q, J = 271 Hz), 125.6 (q, J = 4 Hz), 123.8, 123.3 (J = 4 Hz), 120.7 (q, J = 32 Hz), 108.0, 80.8, 60.2, 35.6, 28.1; 19 F NMR (CDCl 3 , 376 MHz) " -61.1; IR (film) 3317, 2979, 2942, 1691, 1623, 1367, 1328, 1156, 1117, 1053, 977, 813 (R,E)-tert-Butyl 3-(7-methylindolin-2-yl)acrylate (Table 1, entry 8). The title compound was prepared according to the General Procedure from tert-butyl 5-(2-amino-3-methylphenyl)pent-2-ynoate (96 mg, 0.37 mmol). After purification by flash chromatography S-6 (10:1$4:1 hexanes/ethyl acetate), the title compound was isolated as a pale-yellow solid (60 mg, 62% yield) in 89% ee.
HPLC analysis of the product: Diacel CHIRALPAK AD-H column; 3% 2-propanol in hexanes; retention times: 10.0 min (minor), 12.4 min (major).
The second run was performed with the (R)-catalyst. 9, 148.9, 147.8, 128.7, 127.1, 123.0, 122.3, 119.4, 119.0, 80.8, 60.3, 36.5, 28.3, 17.0; IR (film) 3354, 2973 IR (film) 3354, , 2921 IR (film) 3354, , 2851 IR (film) 3354, , 1707 IR (film) 3354, , 1657 IR (film) 3354, , 1599 IR (film) 3354, , 1467 IR (film) 3354, , 1391 IR (film) 3354, , 1365 IR (film) 3354, , 1304 IR (film) 3354, , 1259 IR (film) 3354, , 1154 IR (film) 3354, , 1072 
III. Catalytic Asymmetric !-Additions of Nitrogen Nucleophiles: Intermolecular Reactions
General Procedure. In a nitrogen-filled glovebox (a glovebox is not necessary: see the next paragraph), 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol), TBME (6.0 mL), a stir bar, and catalyst (R)-1 (17.7 mg, 0.0500 mmol; in 2.0 mL of TBME) were added in turn to an oven-dried 20-mL vial. The solution was stirred for 5 min, and then the allenoate (1.00 mmol) was added (in 2.0 mL of TBME). The vial was capped (the cap was wrapped with electrical tape) and then removed immediately from the glovebox. The reaction mixture was stirred at 10 °C for 36 h. The mixture was then concentrated, and the product was purified by column chromatography (visualization with KMnO 4 ).
Note: For the !-addition illustrated in Table 3 , entry 2: in the presence of 0.10 equiv of water, the product was formed in 89% ee and 93% yield; in the presence of 0.50 equiv of water, the product was formed in 89% ee and >95% yield.
Glovebox-free procedure. Catalyst (R)-1 (17.7 mg, 0.0500 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol) were weighed in air and transferred to a 20-mL vial, which was capped with a PTFE-lined septum cap and then wrapped with electrical tape. The vial was evacuated and back-filled with nitrogen (three cycles). Anhydrous TBME (10 mL) was added via syringe, and the reaction mixture was stirred for 5 min. Next, the allenoate (1.00 mmol) was added via syringe, and the vial was cooled to 10 °C. After 36 hours, the reaction mixture was concentrated, and the product was purified by column chromatography. Table 3 , entry 4: 89% ee and 78% yield (run 1); 86% ee and 83% yield (run 2).
Note: For the !-addition illustrated in Table 3 , entry 4: when this reaction was conducted in a capped vial under air, the product was formed in 89% ee and 68% yield (run 1); 87% ee and 72% yield (run 2).
(S,E)-Ethyl 4-(2,2,2-trifluoroacetamido)pent-2-enoate (Table 3 , entry 1). The title compound was prepared according to the General Procedure from (±)-ethyl penta-2,3-dienoate (126 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After purification by column chromatography (4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless oil (108 mg, 90% yield) in 87% ee.
HPLC analysis of the product: Daicel CHIRALPAK AD-H column; 2% 2-propanol in hexanes; retention times: 12.1 min (major), 18.6 min (minor).
The second run was performed with (S)-catalyst. The product was isolated as a colorless oil (104 mg, 87% yield) in 85% ee.
1 H NMR (CDCl 3 , 500 MHz) " 6.86 (dd, J = 5. (Table 3 , entry 2). The title compound was prepared according to the General Procedure from (±)-ethyl hepta-2,3-dienoate (154 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After purification by column chromatography (10:1$4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless oil (118 mg, 88% yield) in 88% ee.
(S,E)-Ethyl 4-(2,2,2-trifluoroacetamido)hept-2-enoate
HPLC analysis of the product: Daicel CHIRALPAK AD-H column; 2% 2-propanol in hexanes; retention times: 10.6 min (major), 22.6 min (minor).
The second run was performed with (S)-catalyst. The product was isolated as a colorless oil (122 mg, 91% yield) in 85% ee.
1 H NMR (CDCl 3 , 500 MHz) " 6.82 (dd, J = 6.1, 15.8 Hz, 1H), 6.36 (br d, J = 7.9 Hz, 1H), 5.94 (dd, J = 1.5, 15.7 Hz, 1H), 4.71-4.62 (m, 1H), 4.22 (q, J = 7.1 Hz, 2H), 1.72-1.64 (m, 2H), 1.47-1.37 (m, 2H), 1.32 (t, J = 7.2 Hz, 3H), 0.98 (t, J = 7.3 Hz, 3H); 13 C NMR (CDCl 3 , 126 MHz) " 165.8, 156.7 (q, J = 38 Hz), 144.9, 122.4, 115.7 (q, J = 289 Hz), 60.8, 50.7, 36.0, 18.8, 14 .2, 13.6; S-8 19 F NMR (CDCl 3 , 282 MHz) " -75.7; IR (film) 3308, 3090, 2965, 2877, 1718, 1663, 1559, 1466, 1370, 1184, 1041, 981, 864, 724 (S,E)-Ethyl 6-methyl-4-(2,2,2-trifluoroacetamido)hept-2-enoate (Table 3 , entry 3). The title compound was prepared according to the General Procedure from (±)-ethyl 6-methylhepta-2,3-dienoate (168 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After purification by column chromatography (10:1$4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless oil (131 mg, 93% yield) in 86% ee.
HPLC analysis of the product: Daicel CHIRALPAK AD-H column; 2% 2-propanol in hexanes; retention times: 9.6 min (major), 19.1 min (minor).
The second run was performed with (S)-catalyst. The product was isolated as a colorless oil (127 mg, 90% yield) in 89% ee. (S,E)-Ethyl 6-phenyl-4-(2,2,2-trifluoroacetamido)hex-2-enoate (Table 3 , entry 4). The title compound was prepared according to the General Procedure from (±)-ethyl 6-phenylhexa-2,3-dienoate (216 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After purification by column chromatography (10:1$4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless oil (158 mg, 96% yield) in 88% ee.
HPLC analysis of the product: Daicel CHIRALPAK AD-H column; 3% 2-propanol in hexanes; retention times: 17.8 min (major), 22.6 min (minor).
S-9
The second run was performed with (S)-catalyst. The product was isolated as a colorless oil (149 mg, 91% yield) in 87% ee. (Table 3 , entry 5). The title compound was prepared according to the General Procedure from (±)-ethyl 8-(benzyloxy)octa-2,3-dienoate (274 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After purification by column chromatography (4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless oil (170 mg, 88% yield) in 88% ee.
(S,E)-Ethyl 8-(benzyloxy)-4-(2,2,2-trifluoroacetamido)oct-2-enoate
HPLC analysis of the product: Daicel CHIRALPAK AD-H column; 2% 2-propanol in hexanes; retention times: 17.5 min (major), 39.9 min (minor).
The second run was performed with (S)-catalyst. The product was isolated as a colorless oil (165 mg, 85% yield) in 90% ee.
1 H NMR (CDCl 3 , 300 MHz) " 7.35-7.26 (m, 5H), 6.78 (dd, J = 6.0, 15.7 Hz, 1H), 6.61 (br d, J = 7.7 Hz, 1H), 5.90 (dd, J = 1.4, 15.7 Hz, 1H), 4.73-4.67 (m, 1H), 4.49 (s, 2H), 4.20 (q, J = 7.1 Hz, 2H), 3.48 (t, J = 6.0 Hz, 2H), 1.75-1.60 (m, 4H), 1.53-1.42 (m, 2H), 1.29 (t, J = 7.1 Hz, 3H); 13 C NMR (CDCl 3 , 126 MHz) " 165.8, 156.7 (q, J = 37 Hz), 144.9, 138.2, 128.4, 127.8, 127.7, 122.4, 115.7 (q, J = 289 Hz), 73.1, 69.7, 60.8, 51.1, 33.4, 29.0, 22.7, 14.2;  19 F NMR (CDCl 3 , 282 MHz) " -75.7; IR (film) 3309, 3088, 2941, 2864, 1719, 1660, 1555, 1454, 1369, 1182, 1041, 980, 868, 736 
S-10
(S,E)-Ethyl 4-(2,2,2-trifluoroacetamido)non-2-en-8-ynoate (Table 3 , entry 6). The title compound was prepared according to the General Procedure from (±)-ethyl nona-2,3-dien-8-ynoate (178 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After purification by column chromatography (4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless waxy solid (127 mg, 87% yield) in 89% ee.
The second run was performed with (S)-catalyst. (S,2E,11Z)-Ethyl 4-(2,2,2-trifluoroacetamido)icosa-2,11-dienoate (Table 3, entry 7). The title compound was prepared according to the General Procedure from (±)-(Z)-ethyl icosa-2,3,11-trienoate (167 mg, 0.500 mmol) and 2,2,2-trifluoroacetamide (28.3 mg, 0.250 mmol). After purification by column chromatography (4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless oil (95 mg, 86% yield) in 87% ee.
HPLC analysis of the product: Diacel CHIRALPAK AD-H column; 1% 2-propanol in hexanes; retention times: 8.1 min (major), 24.3 min (minor).
The second run was performed with (S)-catalyst. The product was isolated as a colorless oil (100 mg, 90% yield) in 87% ee. 
S-11
13 C NMR (CDCl 3 , 126 MHz) " 165. 8, 156.7 (q, J = 37 Hz), 144.9, 130.2, 129.5, 122.5, 115.7 (q, J = 289 Hz), 60.8, 50.9, 34.0, 31.9, 29.8, 29.6, 29.5, 29.33, 29.32, 29.1, 29.0, 27.2, 27.1, 25.5, 22.7, 14 (S,E)-Ethyl 7-methyl 4-(2,2,2-trifluoroacetamido)hept-2-enedioate (Table 3, entry 8). The title compound was prepared according to the General Procedure from (±)-ethyl 7-methyl hepta-2,3-dienedioate (119 mg, 0.600 mmol) and 2,2,2-trifluoroacetamide (33.9 mg, 0.300 mmol). After purification by column chromatography (4:1$2:1 hexanes/ethyl acetate), the title compound was isolated as a colorless oil (63 mg, 68% yield) in 83% ee.
HPLC analysis of the product: Diacel CHIRALPAK AD-H column; 7% 2-propanol in hexanes; retention times: 9.1 min (major), 11.1 min (minor).
The second run was performed with (S)-catalyst. The product was isolated as a colorless oil (62 mg, 67% yield) in 81% ee. 9, 52.3, 50.7, 30.1, 27.9, 14.2; 19 F NMR (CDCl 3 , 282 MHz) " -75.7; IR (film) 3315, 3085, 2985, 2956, 1720, 1661, 1551, 1440, 1371, 1310, 1270, 1179, 1037, 981, 867, 724 (S,E)-Ethyl 6-(thiophen-2-yl)-4-(2,2,2-trifluoroacetamido)hex-2-enoate (Table 3, entry 9). The title compound was prepared according to the General Procedure from (±)-ethyl 6-(thiophen-2-yl)hexa-2,3-dienoate (236 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, S-12 0.500 mmol). After purification by column chromatography (4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless oil (148 mg, 88% yield) in 86% ee.
HPLC analysis of the product: Daicel CHIRALPAK AD-H column; 2% 2-propanol in hexanes; retention times: 17.4 min (major), 21.6 min (minor).
The second run was performed with (S)-catalyst. (S,E)-Methyl 5-cyclopentyl-4-(2,2,2-trifluoroacetamido)pent-2-enoate (eq 3). The title compound was prepared according to the General Procedure from (±)-methyl 5-cyclopentylpenta-2,3-dienoate (180 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After purification by column chromatography (4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless waxy solid (117 mg, 80% yield) in 91% ee.
HPLC analysis of the product: Diacel CHIRALPAK AD-H column; 2% 2-propanol in hexanes; retention times: 15.0 min (major), 29.2 min (minor).
The second run was performed with (S)-catalyst. 
S-13 (S,E)-tert-Butyl 4-(2,2,2-trifluoroacetamido)hept-2-enoate (eq 3).
The title compound was prepared according to the General Procedure from (±)-tert-butyl hepta-2,3-dienoate (109 mg, 0.600 mmol) and 2,2,2-trifluoroacetamide (33.9 mg, 0.300 mmol). After purification by column chromatography (10:1$4:1 hexanes/ethyl acetate), the title compound was isolated as a colorless waxy solid (82 mg, 93% yield) in 90% ee.
HPLC analysis of the product: Diacel CHIRALPAK AD-H column; 2% 2-propanol in hexanes; retention times: 8.6 min (major), 19.3 min (minor).
(S,E)-5-Cyclopentyl-N-methoxy-N-methyl-4-(2,2,2-trifluoroacetamido)pent-2-enamide (eq 4).
The title compound was prepared according to the General Procedure (except 15% catalyst was used) from (±)-5-cyclopentyl-N-methoxy-N-methylpenta-2,3-dienamide (207 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After purification by column chromatography (4:1$2:1 hexanes/ethyl acetate), the title compound was isolated as a colorless waxy solid (96 mg, 60% yield) in 91% ee.
HPLC analysis of the product: Daicel CHIRALPAK AD-H column; 15% 2-propanol in hexanes; retention times: 4.8 min (major), 7.7 min (minor).
The second run was performed with (S)-catalyst. The product was isolated as a colorless waxy solid (97 mg, 60% yield) in 88% ee. S-14 13 C NMR (CDCl 3 , 126 MHz) " 156.5 (q, J = 37 Hz), 143.7, 120.2, 115.8 (q, J = 289 Hz), 61.9, 51.0, 40.6, 36.5, 32.8, 32.5, 25.1, 25.0;  19 F NMR (CDCl 3 , 282 MHz) " -75.8; IR (film) 3263, 3079, 2948, 2870, 1716, 1665, 1626, 1553, 1428, 1387, 1182, 999, 874, 726 
IV. Determination of Absolute Stereochemistry
The absolute stereochemistry of the product in entry 5 of Table 1 (generated with catalyst (R)-1) was determined by converting the illustrated commercially available enantioenriched aminoalcohol into the corresponding !-addition product, and then comparing the HPLC data. The other intramolecular !-addition products were assigned by analogy.
The absolute stereochemistry of the product in entry 3 of Table 3 (generated with catalyst (R)-1) was determined by converting the commercially available (S)-leucinol into the corresponding !-addition product, and then comparing the HPLC data. The other intermolecular !-addition products were assigned by analogy. 2, 151.3, 148.8, 142.2, 122.8, 115.1, 113.0, 80.5, 60.3, 56.1, 710, 1651, 1618, 1457, 1365, 1241, 1151, 1040, 985, 866, 848, 811, 784 , 1651, 1618, 1457, 1365, 1241, 1151, 1040, 985, 866, 848, 811, 784 , 1649, 1618, 1509, 1454, 1367, 1243, 1159, 1038, 816, 740 1, entry 3) . The title cording to the General Procedure from methyl 7-((4-t-2-ynoate (130 mg, 0.50 mmol). After purification by flash es/ethyl acetate), the title compound was isolated as a light-yellow % ee. oduct: Diacel CHIRALCEL OD-H column; 1% 2-propanol in .9 min (minor), 21.5 min (major). formed with the (R)-catalyst. The product was isolated as a lightld) in 94% ee. z) ! 7.00 (dd, J = 5.0, 15.5 Hz, 1H), 6.83 (dt, J = 3.5, 9.5 Hz, 2H), 6.51 (dd, J = 1.5, 15.5 Hz, 1H), 4.25-4.20 (m, 1H), 3.76 (s, 3H), 3.73 (s, 3H), = 8.5 Hz, 1H), 2.22-2.14 (m, 1H), 2.02-1.98 (m, 2H), 1.94-1.86 (m, 1H); Hz) ! 167. 1, 151.2, 150.2, 141.8, 120.6, 114.9, 112.9, 60.1, 55.9, 51.5, 3, 1655, 1512, 1436, 1241, 1177, 1042, 982, 813 S-4 5, 1707, 1649, 1462, 1391, 1365, 1246, 1146, 1042, 982, 813 9, 150.4, 147.7, 127.8, 127.7, 124.9, 123.1, 119.3, 109.5, 80.7, 4, 1483, 1467, 1309, 1248, 1148, 742 1, entry 6) . The title compound to the General Procedure from tert-butyl 5-(2-amino-5-noate (85 mg, 0.31 mmol). After purification by flash chromatography 1, entry 7) . The title according to the General Procedure from tert-butyl 5-(2-amino-5-ent-2-ynoate (81 mg, 0.26 mmol). After purification by flash :1 hexanes/ethyl acetate), the title compound was isolated as a yield) in 88% ee. product: Diacel CHIRALPAK AD-H column; 3% 2-propanol in 16.7 min (minor), 23.7 min (major). erformed with the (R)-catalyst. The product was isolated as a colorless n 87% ee. 5, 153.0, 146.6, 127.7, 124 .9 (q, J = 271 Hz), 125.6 (q, J = 4 ), 120.7 (q, J = 32 Hz), 108.0, 80.8, 60.2, 35.6, 28.1; Hz) " -61.1; 42, 1691 , 1623 , 1367 , 1328 , 1156 , 1117 , 1053 -75.7; 65, 2877, 1718, 1663, 1559, 1466, 1370, 1184, 1041, 981, 864, 724 -75.7; 61, 1713, 1661, 1557, 1471, 1370, 1182, 1096, 1042, 980, 873, 726 3, entry 4) . The title according to the General Procedure from (±)-ethyl 6-phenylhexa-2,3-mol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After hromatography (10:1!4:1 hexanes/ethyl acetate), the title compound s oil (158 mg, 96% yield) in 88% ee. product: Daicel CHIRALPAK AD-H column; 3% 2-propanol in : 17.8 min (major), 22.6 min (minor). erformed with (S)-catalyst. The product was isolated as a colorless oil % ee. 4-(2,2,2-trifluoroacetamido)oct-2-enoate (Table 3, entry 5) . The ared according to the General Procedure from (±)-ethyl 8-ate (274 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 by column chromatography (4:1 hexanes/ethyl acetate), the title s a colorless oil (170 mg, 88% yield) in 88% ee. product: Daicel CHIRALPAK AD-H column; 2% 2-propanol in 17.5 min (major), 39.9 min (minor). erformed with (S)-catalyst. The product was isolated as a colorless oil % ee. 144.9, 138.2, 128.4, 127.8, 127.7, 122.4, 69.7, 60.8, 51.1, 33.4, 29.0, 22.7, 14.2; Hz) ! -75.7; 41, 2864 , 1719 , 1660 , 1555 , 1454 , 1369 , 1182 , 1041 (Table 3 , entry 6). The title according to the General Procedure from (±)-ethyl nona-2,3-dien-8-l) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After romatography (4:1 hexanes/ethyl acetate), the title compound was xy solid (127 mg, 87% yield) in 89% ee. (Table 3 , entry 6). The title according to the General Procedure from (±)-ethyl nona-2,3-dien-8-l) and 2,2,2-trifluoroacetamide (56.5 mg, 0.500 mmol). After romatography (4:1 hexanes/ethyl acetate), the title compound was xy solid (127 mg, 87% yield) in 89% ee. -75.7; 55, 1703, 1660, 1551, 1466, 1370, 1275, 1182, 1041, 978, 866, 723 4-(2,2,2-trifluoroacetamido)hept-2-enedioate (Table 3, entry 8) . The pared according to the General Procedure from (±)-ethyl 7-methyl 19 mg, 0.600 mmol) and 2,2,2-trifluoroacetamide (33.9 mg, 0.300 mmol). umn chromatography (4:1!2:1 hexanes/ethyl acetate), the title as a colorless oil (63 mg, 68% yield) in 83% ee. product: Diacel CHIRALPAK AD-H column; 7% 2-propanol in : 9.1 min (major), 11.1 min (minor). performed with (S)-catalyst. The product was isolated as a colorless oil % ee. MHz) " 7.50 (d, J = 6.6 Hz, 1H), 6.81 (dd, J = 5.7, 15.7 Hz, 1H), 5.95 (dd, J (m, 1H), 4.22 (q, J = 7.1 Hz, 2H), 3.72 (s, 3H), 2.56-2.42 (m, 2H), 2.11-2.02 z, 3H); MHz) " 174.2, 165.6, 157.0 (d, J = 38 Hz), 144.0, 122.9, 115.7 (d, J = 289 , 27.9, 14.2; MHz) " -75.7; 2985 , 2956 , 1720 , 1661 , 1551 , 1440 , 1371 , 1310 , 1270 , 1179 , 1037 (Table 3 , entry 9). prepared according to the General Procedure from (±)-ethyl 6-dienoate (236 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, fication by column chromatography (4:1 hexanes/ethyl acetate), the title as a colorless oil (148 mg, 88% yield) in 86% ee. 4-(2,2,2-trifluoroacetamido)hex-2-enoate (Table 3, entry 9) . prepared according to the General Procedure from (±)-ethyl 6-dienoate (236 mg, 1.00 mmol) and 2,2,2-trifluoroacetamide (56.5 mg, ication by column chromatography (4:1 hexanes/ethyl acetate), the title as a colorless oil (148 mg, 88% yield) in 86% ee. product: Daicel CHIRALPAK AD-H column; 2% 2-propanol in : 17.4 min (major), 21.6 min (minor). erformed with (S)-catalyst. The product was isolated as a colorless oil % ee. MHz) " (dd, J = 1.2, 5.2 Hz, 1H), 6.93 (dd, J = 3.4, 5.1 Hz, 1H), 6.88-6.76 z, 1H), 5.93 (dd, J = 1.5, 15.7 Hz, 1H), 4.74-4.68 (m, 1H), 4.21 (q, J = 7.1 z, 2H), 2.14-1.98 (m, 2H), 1.30 (t, J = 7.1 Hz, 3H); ! "#,*! ! eq 3a cd for C 14 H 17 F 3 NO 3 S (M+H) 336.2, found 336.2; CHCl 3 ). ,2-trifluoroacetamido)hept-2-enoate (eq 3). The title compound was General Procedure from (±)-tert-butyl hepta-2,3-dienoate (109 mg, luoroacetamide (33.9 mg, 0.300 mmol). After purification by column :1 hexanes/ethyl acetate), the title compound was isolated as a g, 93% yield) in 90% ee.
! "#,$! !
! "#,-! ! eq 4! S-13 for C 13 H 20 F 3 NNaO 3 (M+Na) 318.1, found 318.1; HCl 3 ). 
